Lakewood Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.3M | Hold |
|
|||||
|
2025
Q1 | $21.1M | Buy |
|
|||||
|
2024
Q4 | $20.6M | Hold |
|
|||||
|
2024
Q3 | $22M | Hold |
|
|||||
|
2024
Q2 | $23.1M | Sell |
|
|||||
|
2024
Q1 | $30.5M | Sell |
|
|||||
|
2023
Q4 | $27.8M | Buy |
|
|||||
|
2023
Q3 | $17.2M | Hold |
|
|||||
|
2023
Q2 | $18.4M | Hold |
|
|||||
|
2023
Q1 | $17.7M | Hold |
|
|||||
|
2022
Q4 | $19.1M | Sell |
|
|||||
|
2022
Q3 | $20.8M | Sell |
|
|||||
|
2022
Q2 | $31M | Buy |
|
|||||
|
2022
Q1 | $21.9M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $45.9M | Sell |
|
|||||
|
2021
Q1 | $47.2M | Sell |
|
|||||
|
2020
Q4 | $44.2M | Sell |
|
|||||
|
2020
Q3 | $44.8M | Sell |
|
|||||
|
2020
Q2 | $39.2M | Buy |
|